302 related articles for article (PubMed ID: 25155314)
1. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery.
Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T
Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study.
Ye J; Ren Y; Wei Z; Peng J; Chen C; Song W; Tan M; He Y; Yuan Y
Surg Oncol; 2018 Sep; 27(3):456-461. PubMed ID: 30217302
[TBL] [Abstract][Full Text] [Related]
3. "Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances".
Arjona-Sánchez A; Cadenas-Febres A; Cabrera-Bermon J; Muñoz-Casares FC; Casado-Adam A; Sánchez-Hidalgo JM; López-Andreu M; Briceño-Delgado J; Rufián-Peña S
Eur J Surg Oncol; 2016 Jun; 42(6):869-76. PubMed ID: 26898841
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
Sin EI; Chia CS; Tan GHC; Soo KC; Teo MC
Int J Hyperthermia; 2017 Sep; 33(6):690-695. PubMed ID: 28540777
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of recurrent/relapsed ovarian granulosa cell tumor: a single-center experience.
Al-Badawi IA; Abu-Zaid A; Azzam A; AlOmar O; AlHusaini H; Amin T
J Obstet Gynaecol Res; 2014 Sep; 40(9):2066-75. PubMed ID: 25181627
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
Pili-Floury S; Royer B; Bartholin F; Crumiere N; Combe M; Chalopin JM; Pivot X; Heyd B; Chauffert B; Samain E
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):199-203. PubMed ID: 21306815
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
Bouhadjari N; Gabato W; Calabrese D; Msika S; Keita H
Eur J Surg Oncol; 2016 Feb; 42(2):219-23. PubMed ID: 26278017
[TBL] [Abstract][Full Text] [Related]
8. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
Zivanovic O; Abramian A; Kullmann M; Fuhrmann C; Coch C; Hoeller T; Ruehs H; Keyver-Paik MD; Rudlowski C; Weber S; Kiefer N; Poelcher ML; Thiesler T; Rostamzadeh B; Mallmann M; Schaefer N; Permantier M; Latten S; Kalff J; Thomale J; Jaehde U; Kuhn WC
Int J Cancer; 2015 Feb; 136(3):699-708. PubMed ID: 24895230
[TBL] [Abstract][Full Text] [Related]
9. Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy.
Kapoor R; Robinson KA; Cata JP; Owusu-Agyemang P; Soliz JM; Hernandez M; Mansfield P; Badgwell B
Int J Hyperthermia; 2019; 36(1):493-498. PubMed ID: 30935256
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy.
Cheng CC; Yeh HC; Su PW; Ho CL; Chang SC
Int J Hyperthermia; 2024; 41(1):2304250. PubMed ID: 38342495
[TBL] [Abstract][Full Text] [Related]
11. Anesthetic management and renal function in pediatric patients undergoing cytoreductive surgery with continuous hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin.
Owusu-Agyemang P; Arunkumar R; Green H; Hurst D; Landoski K; Hayes-Jordan A
Ann Surg Oncol; 2012 Aug; 19(8):2652-6. PubMed ID: 22451231
[TBL] [Abstract][Full Text] [Related]
12. Acute Kidney Injury Following Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.
Chen KL; Shamavonian R; Karpes JB; Alzahrani NA; Morris DL
Anticancer Res; 2021 Mar; 41(3):1641-1646. PubMed ID: 33788760
[TBL] [Abstract][Full Text] [Related]
13. Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
Bhagwandin SB; Naffouje S; Salti G
J Surg Oncol; 2015 Mar; 111(3):324-7. PubMed ID: 25557653
[TBL] [Abstract][Full Text] [Related]
14. Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.
D'Hondt V; Goffin F; Roca L; Dresse D; Leroy C; Kerger J; Cordier L; de Forges H; Veys I; Liberale G
Int J Gynecol Cancer; 2016 Jun; 26(5):912-7. PubMed ID: 27051055
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes
Acs M; Halmy L; Isgandarova S; Blaj S; Gerken M; Hormann B; Piso P
Anticancer Res; 2022 Feb; 42(2):1019-1029. PubMed ID: 35093903
[TBL] [Abstract][Full Text] [Related]
16. Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used.
Gómez-Ruiz ÁJ; González-Gil A; Gil J; Alconchel F; Navarro-Barrios Á; Gil-Gómez E; Martínez J; Nieto A; García-Palenciano C; Cascales-Campos PA
Langenbecks Arch Surg; 2021 Nov; 406(7):2449-2456. PubMed ID: 34283300
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intraperitonal chemotherapy is an independent risk factor for development of acute kidney injury.
Dagel T; Misirlioglu S; Tanju S; Afsar B; Selcukbiricik F; Erus S; Vatansever D; Balik E; Taskiran C; Dilege S; Molinas Mandel N; Bugra D; Yalti T; Kanbay M
J BUON; 2018; 23(5):1528-1533. PubMed ID: 30570881
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study.
Lim MC; Kang S; Choi J; Song YJ; Park S; Seo SS; Park SY
Ann Surg Oncol; 2009 Apr; 16(4):993-1000. PubMed ID: 19169758
[TBL] [Abstract][Full Text] [Related]
19. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
20. Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients - A retrospective analysis.
Vachez E; Kefleyesus A; Bakrin N; Ranchon F; Rioufol C; Vassal O; Al-Hadeedi O; Kepenekian V; Glehen O
Eur J Surg Oncol; 2024 Feb; 50(2):107955. PubMed ID: 38219699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
